Home › Seizures › Texas › Dallas
Seizures clinical trials in Dallas, TX
6 studies for Seizures are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Prospective Natural History Study of POLG Disease
RecruitingObservational study
- Baylor Hospital, Dallas
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
RecruitingPhase 3
- Children's Health Specialty Center, Dallas
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
RecruitingPhase 3
- UT Southwestern Medical Center, Dallas
Pharmacological Modulation of Brain Oscillations in Memory Processing
RecruitingEarly phase 1Healthy volunteers welcome
- University of Texas Southwestern Medical Center, Dallas
Pediatric Dose Optimization for Seizures in Emergency Medical Services
RecruitingPhase 3
- University of Texas Southwestern, Dallas
Epilepsy Learning Healthcare System (ELHS)
RecruitingObservational study
- UT Southwestern Children's Dallas, Dallas
About Seizures
Seizures are caused by sudden, abnormal electrical activity in the brain. They can be mild or severe. Learn about the types, causes, and treatments.
More about Seizures on MedlinePlus
Seizures trials in other cities
- Washington, DC12 studies
- New York City, NY11 studies
- Philadelphia, PA10 studies
- Boston, MA8 studies
- Houston, TX7 studies
- Birmingham, AL7 studies
- Cincinnati, OH6 studies
- Chicago, IL6 studies
- Durham, NC6 studies
- San Francisco, CA5 studies
- Portland, OR5 studies
- Aurora, CO5 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer52 studies
- Heart Failure42 studies
- Metastatic Cancer42 studies
- Cancer (all types)38 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity31 studies
- Ovarian Cancer28 studies
- Bladder Cancer27 studies
- Lung Cancer27 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.